Skip to main content
. 2019 Apr 26;11(5):949. doi: 10.3390/nu11050949

Table 1.

Baseline characteristics of the participants by study group.

Nutraceutical Combination (n = 20) Placebo (n = 20) p *
Age, years 59.3 (9.5) 63.5 (12.3) 0.219
Women, n (%) 11 (55) 16 (80) 0.088
Current smokers, n (%) 3 (15) 2 (10) 0.500
Weight, kg 74.7 (14.6) 72.0 (17.6) 0.600
Body mass index, kg/m2 26.9 (3.8) 27.3 (4.4) 0.159
Waist circumference, cm 97.6 (9.6) 97.1 (10.8) 0.878
Office systolic BP, mm Hg 125.2 (9.9) 127.1 (19.8) 0.562
Office diastolic BP, mm Hg 76.4 (6.7) 73.0 (11.7) 0.275
Total cholesterol, mmol/L 6.08 (0.62) 5.83 (0.47) 0.175
LDL cholesterol, mmol/L 3.91 (0.55) 3.71 (0.48) 0.223
HDL cholesterol, mmol/L 1.44 (0.37) 1.57 (0.14) 0.286
Triglycerides, mmol/L 1.53 (0.87) 1.38 (0.66) 0.271
REGICOR risk scale, n (%)
Low Risk 12 (60) 10 (50) 0.376
Moderate Risk 8 (40) 10 (50)
MedDiet score 7.6 (2.0) 8.6 (1.9) 0.123

Values are means (SD) except for qualitative variables, which are expressed as n (%). BP: blood pressure; LDL: low-density lipoprotein; HDL: high-density lipoprotein; REGICOR: Registre Gironí del Cor; MedDiet: Mediterranean diet. * p value for comparisons between groups by chi square test for categorical variables and one-way ANOVA for continuous variables.